Chronic brain inflammation leads to a decline in hippocampal NMDA-Rl receptors

Journal of Neuroinflammation

Volumn 1, Issue , 2004, Pages

  Rosi, Susanna ^a   Ramirez Amaya, Victor ^a   Hauss Wegrzyniak, Beatrice ^a   Wenk, Gary L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; LIPOPOLYSACCHARIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRITIUM;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BINDING AFFINITY; BRAIN DEGENERATION; BRAIN DISEASE; BRAIN ELECTROPHYSIOLOGY; BRAIN FOURTH VENTRICLE; BRAIN NERVE CELL; CHRONIC DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; ENTORHINAL CORTEX; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; ISOTOPE LABELING; MALE; NONHUMAN; PROTEIN FUNCTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; TEMPORAL LOBE;

EID: 4344622201     PISSN: 17422094     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-2094-1-12     Document Type: Article

References (40)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cooper NR, Eikelenboom P, Emmerling M, Fiebich B, Finch CE, Frautschy S, Griffin WST, Hampel H, Landreth G, McGeer PL, Mrak R, MacKenzie I, O'Banion K, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray A: Inflammation in Alzheimer's disease. Neurobiol Aging 2000, 21:383-421.
2. McGeer EG, McGeer PL: The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 1998, 33:371-378.
3. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE: In-vivo measurement of activated microglia in dementia. Lancet 2001, 358: 461-467.
4. DeToledo-Morrell L, Sullivan MP, Morrell F, Wilson RS, Bennett DA, Spencer S: Alzheimer's disease: in vivo detection of differential vulnerability of brain regions. Neurobiol Aging 1997, 18:463-468.
5. Gomez-Isla T, Price JL, McKeel Jr DW, Morris JC, Growdon JH, Hyman B T: Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996, 16:4491-4500.
6. Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL: Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 1998, 780:294-303.
7. Wenk GL, Barnes CA: Regional changes in the hippocampal density of AMPA and NMDA receptors across the lifespan of the rat. Brain Res 2000, 885: 1-5.
8. Hauss-Wegrzyniak B, Galons JP, Wenk GL: Quantitative volumetric analysis of brain magnetic resonance imaging from rat with chronic neuroinflammation and correlation with histology. Exp Neurol 2000, 165:347-354.
9. Hauss-Wegrzyniak B, Lynch MA, Vraniak PD, Wenk GL: Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp Neurol 2002,176:336-341.
10. Albin RL, Greenamyre JT: Alternative excitotoxic hypotheses. Neurology 1992, 42:733-738.
11. Cotman C, Bridges R, Taube J, Clark AS, Geddes J and Monaghan D: The role of the NMDA receptor in central nervous system plasticity and pathology. J NIH Res 1989, 1:65-74.
12. Rogawski M, Wenk GL: The neuropharmacological basis for Memantine in the treatment of Alzheimer's disease. CNS Drug Rev 2003, 9:275-308.
13. Wenk GL, McGann, K Fiorucci S, Mencarelli A, Hauss-Wegrzyniak B, Del Soldato P: Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons. Eur J Pharmacol 2000, 402:77-85.
14. Wenk GL, Hauss-Wegrzyniak B: Animal models of chronic neuroinflammation as a model of Alzheimer's Disease. In Inflammatory Events in Neurodegeneration. Edited by Bondy S, Campbell A. Scottsdale, AZ: Prominent Press; 2001:83-87.
15. Wenk GL, Hauss-Wegrzyniak B: Chronic intracerebral LPS as a model of neuroinflammation. In Neuroinflammation: Mechanisms and Management. 2nd Edition. Edited by Wood PL. Totowa, NJ: Humana Press; 2003:137-150.
16. Obrenovitch TP, Urenjak J: Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog Neurobiol 1997, 51:39-87.
17. Riedel G, Platt B, Micheau J: Glutamate receptor function in learning and memory. Behav Brain Res 2003, 140:1-47.
18. Baskys A, Adamchik Y: Neuroprotective effects of extracellular glutamate are absent in hippocampal organotypic cultures treated with the amyloid peptide Abeta (25-35). Brain Res 2001, 907:188-194.
19. Bi H, Sze CI: N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. J Neurol Sci 2002, 200:11-18.
20. Biegon A, Alvarado M, Budinger TF, Grossman R, Hensley K, West MS, Kotake Y, M Ono , Floyd RA: Region-selective effects of neuroinflammation and antioxidant treatment on peripheral benzodiazepine receptors and NMDA receptors in the rat brain. J Neurochem 2002, 82:924-934.
21. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A: Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998, 391: 281-285.
22. Bal-Price, Brown G C: Inflammatory Neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate realease and excitotoxicity. J Neurosci 2001, 21:6480-6491.
23. Morimoto K, Murasugi T, Oda T: Acute Neuroinflammation Exacerbates Excitotoxicity in Rat Hippocampus in Vivo. Exp Neurol 2002, 177: 95-104
24. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M: Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003, 23:8692-8700.
25. Hauss-Wegrzyniak B, Vannucchi MG, Wenk GL: Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats. Brain Res 2000, 859:157-166.
26. Hauss-Wegrzyniak B, Vraniak P, Wenk GL: The effects of a novel NSAID upon chronic neuroinflammation are age dependent. Neurobiol Aging, 1999, 20:305-313.
27. Hauss-Wegrzyniak B, Vraniak P, Wenk GL: LPS-induced neuroinflammatory effects do not recover with time. Neuroreport 2000, 11:1759-1763.
28. Monyer H, Sprengel R, Shoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH: Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 1992, 256:1217-1221.
29. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with folin phenol reagent. J Biol Chem 1951, 193:265-275.
30. Iwakiri M, Mizukami K, Ishikawa M, Hidaka S, Asada T: Alterations of NMDAR1 and NMDAR2A/B immunoreactivity in the hippocampus after perforant pathway lesion. Neuropathology 2002, 22:154-160.
31. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
32. Quan N, Sundar SK , Weiss JM: Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J Neuroimmunol 1994, 49:125-134.
33. 2 in rat astrocyte cultures: modulatory effect of neuropeptides. Endocrinology 1989, 124:3125-3127.
34. Goossens V, Grooten J, De Vos K, Fiers W: Direct evidence for tumor necrosis factor-induced mitochondrial reative oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA, 1995, 92:8115-8119.
35. Minghetti L, Levi G: Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J Neurochem 1995, 65:2690-2698.
36. Brezzi P,Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A: CXCR4-activated astrocyte glutamate release via TNF alpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001, 4:702-710.
37. Rothsteins MB, Djali S, Buchhalter JR: Inhibition of glutamate uptake with L-transpyrrolidine-2,4-dicarboxylate potentiates glutamate neurotoxicity in primary hippocampal cultures. J Neurochem 1993, 61:2099-2103.
38. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW: Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sc. USA 1993, 90: 6591-6595.
39. Wenk GL, McGann K, Hauss-Wegrzyniak B, Rosi S: (2003) The toxicity of tumor necrosis factor-α upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for Alzheimer's disease. Neurosci 2003, 121:719-729.
40. Mesches MH, Gemma C, Veng LM, Allgeier C, Young DA, Browning MD, Bickford PC: Sulindac improves memory and increases NMDA receptor subunits in aged Fisher 344 rats. Neurobiol Aging 2004, 25:315-324.